Report Detail
Global Biological Defense Measures Market Growth (Status and Outlook) 2023-2029
- RnM4502062 |
- 10 January, 2023 |
- Global |
- 121 Pages |
- LPI(LP Information) |
- Service & Software
Biological Defense Measure is a set of medical or military measures. These are taken in response to the demand for restoring the biosecurity of a country against biological toxins or infectious agents. The agents can be used with the intent to kill or infect humans, animals, or the environment and to instigate biological warfare. Biological agents used during bioterrorism are usually living organisms. These can include bacteria, viruses, fungi, or toxins that are deliberately used to sicken and kill creating social and economic turmoil.
LPI (LP Information)' newest research report, the “Biological Defense Measures Industry Forecast” looks at past sales and reviews total world Biological Defense Measures sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Defense Measures sales for 2023 through 2029. With Biological Defense Measures sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Defense Measures industry.
This Insight Report provides a comprehensive analysis of the global Biological Defense Measures landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Defense Measures portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Defense Measures market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Defense Measures and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Defense Measures.
The global Biological Defense Measures market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biological Defense Measures is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biological Defense Measures is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biological Defense Measures is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biological Defense Measures players cover Alnylam Pharmaceuticals Inc, Aeolus Pharmaceuticals, Achaogen, Arbutus Biopharma, Altimmune Inc, Bavarian Nordic, Cleveland Biolabs, Emergent Biosolutions Inc and Elusys Therapeutics Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Defense Measures market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Biological
Chemical
Radiological
Nuclear (CBRN) Warfare Agents
Others
Segmentation by application
Medical
Military
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alnylam Pharmaceuticals Inc
Aeolus Pharmaceuticals
Achaogen
Arbutus Biopharma
Altimmune Inc
Bavarian Nordic
Cleveland Biolabs
Emergent Biosolutions Inc
Elusys Therapeutics Inc
Dynport Vaccine Company
Dynavax Technologies Corporation
Hytest
Ichor Medical Systems
GSK
SIGA Technologies
Sanofi
Soligenix
Ology Bioservices
PharmAthene
Xoma Corporation
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biological Defense Measures Market Size 2018-2029
- 2.1.2 Biological Defense Measures Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Biological Defense Measures Segment by Type
- 2.2.1 Biological
- 2.2.2 Chemical
- 2.2.3 Radiological
- 2.2.4 Nuclear (CBRN) Warfare Agents
- 2.2.5 Others
- 2.3 Biological Defense Measures Market Size by Type
- 2.3.1 Biological Defense Measures Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Biological Defense Measures Market Size Market Share by Type (2018-2023)
- 2.4 Biological Defense Measures Segment by Application
- 2.4.1 Medical
- 2.4.2 Military
- 2.5 Biological Defense Measures Market Size by Application
- 2.5.1 Biological Defense Measures Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Biological Defense Measures Market Size Market Share by Application (2018-2023)
3 Biological Defense Measures Market Size by Player
- 3.1 Biological Defense Measures Market Size Market Share by Players
- 3.1.1 Global Biological Defense Measures Revenue by Players (2018-2023)
- 3.1.2 Global Biological Defense Measures Revenue Market Share by Players (2018-2023)
- 3.2 Global Biological Defense Measures Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Biological Defense Measures by Regions
- 4.1 Biological Defense Measures Market Size by Regions (2018-2023)
- 4.2 Americas Biological Defense Measures Market Size Growth (2018-2023)
- 4.3 APAC Biological Defense Measures Market Size Growth (2018-2023)
- 4.4 Europe Biological Defense Measures Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Biological Defense Measures Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Biological Defense Measures Market Size by Country (2018-2023)
- 5.2 Americas Biological Defense Measures Market Size by Type (2018-2023)
- 5.3 Americas Biological Defense Measures Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Biological Defense Measures Market Size by Region (2018-2023)
- 6.2 APAC Biological Defense Measures Market Size by Type (2018-2023)
- 6.3 APAC Biological Defense Measures Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Biological Defense Measures by Country (2018-2023)
- 7.2 Europe Biological Defense Measures Market Size by Type (2018-2023)
- 7.3 Europe Biological Defense Measures Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Biological Defense Measures by Region (2018-2023)
- 8.2 Middle East & Africa Biological Defense Measures Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Biological Defense Measures Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Biological Defense Measures Market Forecast
- 10.1 Global Biological Defense Measures Forecast by Regions (2024-2029)
- 10.1.1 Global Biological Defense Measures Forecast by Regions (2024-2029)
- 10.1.2 Americas Biological Defense Measures Forecast
- 10.1.3 APAC Biological Defense Measures Forecast
- 10.1.4 Europe Biological Defense Measures Forecast
- 10.1.5 Middle East & Africa Biological Defense Measures Forecast
- 10.2 Americas Biological Defense Measures Forecast by Country (2024-2029)
- 10.2.1 United States Biological Defense Measures Market Forecast
- 10.2.2 Canada Biological Defense Measures Market Forecast
- 10.2.3 Mexico Biological Defense Measures Market Forecast
- 10.2.4 Brazil Biological Defense Measures Market Forecast
- 10.3 APAC Biological Defense Measures Forecast by Region (2024-2029)
- 10.3.1 China Biological Defense Measures Market Forecast
- 10.3.2 Japan Biological Defense Measures Market Forecast
- 10.3.3 Korea Biological Defense Measures Market Forecast
- 10.3.4 Southeast Asia Biological Defense Measures Market Forecast
- 10.3.5 India Biological Defense Measures Market Forecast
- 10.3.6 Australia Biological Defense Measures Market Forecast
- 10.4 Europe Biological Defense Measures Forecast by Country (2024-2029)
- 10.4.1 Germany Biological Defense Measures Market Forecast
- 10.4.2 France Biological Defense Measures Market Forecast
- 10.4.3 UK Biological Defense Measures Market Forecast
- 10.4.4 Italy Biological Defense Measures Market Forecast
- 10.4.5 Russia Biological Defense Measures Market Forecast
- 10.5 Middle East & Africa Biological Defense Measures Forecast by Region (2024-2029)
- 10.5.1 Egypt Biological Defense Measures Market Forecast
- 10.5.2 South Africa Biological Defense Measures Market Forecast
- 10.5.3 Israel Biological Defense Measures Market Forecast
- 10.5.4 Turkey Biological Defense Measures Market Forecast
- 10.5.5 GCC Countries Biological Defense Measures Market Forecast
- 10.6 Global Biological Defense Measures Forecast by Type (2024-2029)
- 10.7 Global Biological Defense Measures Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Alnylam Pharmaceuticals Inc
- 11.1.1 Alnylam Pharmaceuticals Inc Company Information
- 11.1.2 Alnylam Pharmaceuticals Inc Biological Defense Measures Product Offered
- 11.1.3 Alnylam Pharmaceuticals Inc Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Alnylam Pharmaceuticals Inc Main Business Overview
- 11.1.5 Alnylam Pharmaceuticals Inc Latest Developments
- 11.2 Aeolus Pharmaceuticals
- 11.2.1 Aeolus Pharmaceuticals Company Information
- 11.2.2 Aeolus Pharmaceuticals Biological Defense Measures Product Offered
- 11.2.3 Aeolus Pharmaceuticals Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Aeolus Pharmaceuticals Main Business Overview
- 11.2.5 Aeolus Pharmaceuticals Latest Developments
- 11.3 Achaogen
- 11.3.1 Achaogen Company Information
- 11.3.2 Achaogen Biological Defense Measures Product Offered
- 11.3.3 Achaogen Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Achaogen Main Business Overview
- 11.3.5 Achaogen Latest Developments
- 11.4 Arbutus Biopharma
- 11.4.1 Arbutus Biopharma Company Information
- 11.4.2 Arbutus Biopharma Biological Defense Measures Product Offered
- 11.4.3 Arbutus Biopharma Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Arbutus Biopharma Main Business Overview
- 11.4.5 Arbutus Biopharma Latest Developments
- 11.5 Altimmune Inc
- 11.5.1 Altimmune Inc Company Information
- 11.5.2 Altimmune Inc Biological Defense Measures Product Offered
- 11.5.3 Altimmune Inc Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Altimmune Inc Main Business Overview
- 11.5.5 Altimmune Inc Latest Developments
- 11.6 Bavarian Nordic
- 11.6.1 Bavarian Nordic Company Information
- 11.6.2 Bavarian Nordic Biological Defense Measures Product Offered
- 11.6.3 Bavarian Nordic Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Bavarian Nordic Main Business Overview
- 11.6.5 Bavarian Nordic Latest Developments
- 11.7 Cleveland Biolabs
- 11.7.1 Cleveland Biolabs Company Information
- 11.7.2 Cleveland Biolabs Biological Defense Measures Product Offered
- 11.7.3 Cleveland Biolabs Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Cleveland Biolabs Main Business Overview
- 11.7.5 Cleveland Biolabs Latest Developments
- 11.8 Emergent Biosolutions Inc
- 11.8.1 Emergent Biosolutions Inc Company Information
- 11.8.2 Emergent Biosolutions Inc Biological Defense Measures Product Offered
- 11.8.3 Emergent Biosolutions Inc Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Emergent Biosolutions Inc Main Business Overview
- 11.8.5 Emergent Biosolutions Inc Latest Developments
- 11.9 Elusys Therapeutics Inc
- 11.9.1 Elusys Therapeutics Inc Company Information
- 11.9.2 Elusys Therapeutics Inc Biological Defense Measures Product Offered
- 11.9.3 Elusys Therapeutics Inc Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Elusys Therapeutics Inc Main Business Overview
- 11.9.5 Elusys Therapeutics Inc Latest Developments
- 11.10 Dynport Vaccine Company
- 11.10.1 Dynport Vaccine Company Company Information
- 11.10.2 Dynport Vaccine Company Biological Defense Measures Product Offered
- 11.10.3 Dynport Vaccine Company Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Dynport Vaccine Company Main Business Overview
- 11.10.5 Dynport Vaccine Company Latest Developments
- 11.11 Dynavax Technologies Corporation
- 11.11.1 Dynavax Technologies Corporation Company Information
- 11.11.2 Dynavax Technologies Corporation Biological Defense Measures Product Offered
- 11.11.3 Dynavax Technologies Corporation Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Dynavax Technologies Corporation Main Business Overview
- 11.11.5 Dynavax Technologies Corporation Latest Developments
- 11.12 Hytest
- 11.12.1 Hytest Company Information
- 11.12.2 Hytest Biological Defense Measures Product Offered
- 11.12.3 Hytest Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Hytest Main Business Overview
- 11.12.5 Hytest Latest Developments
- 11.13 Ichor Medical Systems
- 11.13.1 Ichor Medical Systems Company Information
- 11.13.2 Ichor Medical Systems Biological Defense Measures Product Offered
- 11.13.3 Ichor Medical Systems Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Ichor Medical Systems Main Business Overview
- 11.13.5 Ichor Medical Systems Latest Developments
- 11.14 GSK
- 11.14.1 GSK Company Information
- 11.14.2 GSK Biological Defense Measures Product Offered
- 11.14.3 GSK Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 GSK Main Business Overview
- 11.14.5 GSK Latest Developments
- 11.15 SIGA Technologies
- 11.15.1 SIGA Technologies Company Information
- 11.15.2 SIGA Technologies Biological Defense Measures Product Offered
- 11.15.3 SIGA Technologies Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 SIGA Technologies Main Business Overview
- 11.15.5 SIGA Technologies Latest Developments
- 11.16 Sanofi
- 11.16.1 Sanofi Company Information
- 11.16.2 Sanofi Biological Defense Measures Product Offered
- 11.16.3 Sanofi Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 Sanofi Main Business Overview
- 11.16.5 Sanofi Latest Developments
- 11.17 Soligenix
- 11.17.1 Soligenix Company Information
- 11.17.2 Soligenix Biological Defense Measures Product Offered
- 11.17.3 Soligenix Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 Soligenix Main Business Overview
- 11.17.5 Soligenix Latest Developments
- 11.18 Ology Bioservices
- 11.18.1 Ology Bioservices Company Information
- 11.18.2 Ology Bioservices Biological Defense Measures Product Offered
- 11.18.3 Ology Bioservices Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Ology Bioservices Main Business Overview
- 11.18.5 Ology Bioservices Latest Developments
- 11.19 PharmAthene
- 11.19.1 PharmAthene Company Information
- 11.19.2 PharmAthene Biological Defense Measures Product Offered
- 11.19.3 PharmAthene Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 PharmAthene Main Business Overview
- 11.19.5 PharmAthene Latest Developments
- 11.20 Xoma Corporation
- 11.20.1 Xoma Corporation Company Information
- 11.20.2 Xoma Corporation Biological Defense Measures Product Offered
- 11.20.3 Xoma Corporation Biological Defense Measures Revenue, Gross Margin and Market Share (2018-2023)
- 11.20.4 Xoma Corporation Main Business Overview
- 11.20.5 Xoma Corporation Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Biological Defense Measures. Industry analysis & Market Report on Biological Defense Measures is a syndicated market report, published as Global Biological Defense Measures Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Biological Defense Measures market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
